JP2017517557A5 - - Google Patents

Download PDF

Info

Publication number
JP2017517557A5
JP2017517557A5 JP2016572736A JP2016572736A JP2017517557A5 JP 2017517557 A5 JP2017517557 A5 JP 2017517557A5 JP 2016572736 A JP2016572736 A JP 2016572736A JP 2016572736 A JP2016572736 A JP 2016572736A JP 2017517557 A5 JP2017517557 A5 JP 2017517557A5
Authority
JP
Japan
Prior art keywords
hybrid composition
fibers
gel
disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016572736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517557A (ja
Filing date
Publication date
Priority claimed from GBGB1410506.8A external-priority patent/GB201410506D0/en
Application filed filed Critical
Publication of JP2017517557A publication Critical patent/JP2017517557A/ja
Publication of JP2017517557A5 publication Critical patent/JP2017517557A5/ja
Pending legal-status Critical Current

Links

JP2016572736A 2014-06-12 2015-06-09 ハイブリッド組成物 Pending JP2017517557A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1410506.8A GB201410506D0 (en) 2014-06-12 2014-06-12 Hybrid composition
GB1410506.8 2014-06-12
PCT/GB2015/051672 WO2015189586A1 (en) 2014-06-12 2015-06-09 Hybrid composition

Publications (2)

Publication Number Publication Date
JP2017517557A JP2017517557A (ja) 2017-06-29
JP2017517557A5 true JP2017517557A5 (cg-RX-API-DMAC7.html) 2018-07-12

Family

ID=51266502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572736A Pending JP2017517557A (ja) 2014-06-12 2015-06-09 ハイブリッド組成物

Country Status (7)

Country Link
US (1) US20170119930A1 (cg-RX-API-DMAC7.html)
EP (1) EP3154599B1 (cg-RX-API-DMAC7.html)
JP (1) JP2017517557A (cg-RX-API-DMAC7.html)
CA (1) CA2951448A1 (cg-RX-API-DMAC7.html)
GB (1) GB201410506D0 (cg-RX-API-DMAC7.html)
SG (1) SG11201610353TA (cg-RX-API-DMAC7.html)
WO (1) WO2015189586A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201513996D0 (en) 2015-08-07 2015-09-23 Cell Therapy Ltd Immuno-oncology mesodermal progenitor (IOMP) cell
US12390494B2 (en) 2016-07-05 2025-08-19 Asher Holzer Compositions and methods for treating heart disease
EP3684433B1 (en) * 2017-09-20 2022-07-06 Novadip Biosciences Biomaterial comprising adipose-derived stem cells and method for producing the same
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
GB201900554D0 (en) 2019-01-15 2019-03-06 Cell Therapy Ltd Mesodermal killer (mk) cell
WO2020148520A1 (en) 2019-01-15 2020-07-23 Cell Therapy Limited Mesodermal killer (mk) cell
CN114748682A (zh) * 2022-04-26 2022-07-15 深圳湾实验室 用于制备烧创伤敷料的组合物及其制剂和制备方法
CN114748683A (zh) * 2022-04-26 2022-07-15 深圳湾实验室 用于制备烧创伤敷料的组合物及其制剂和制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008252907A1 (en) * 2007-05-22 2008-11-27 Cinvention Ag Partially degradable scaffolds for biomedical applications
US8673323B2 (en) * 2011-01-07 2014-03-18 Washington University Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system

Similar Documents

Publication Publication Date Title
JP2017200474A5 (cg-RX-API-DMAC7.html)
HRP20170657T1 (hr) Imunomodulatorne ishodišne (imp) stanice
Vyas et al. 3D printing of silk microparticle reinforced polycaprolactone scaffolds for tissue engineering applications
Netrusov et al. Exopolysaccharides producing bacteria: a review
JP2004528806A5 (cg-RX-API-DMAC7.html)
Arlov et al. Biomimetic sulphated alginate hydrogels suppress IL-1β-induced inflammatory responses in human chondrocytes
JP2024506682A5 (cg-RX-API-DMAC7.html)
JP2019533450A5 (cg-RX-API-DMAC7.html)
JP2023126852A5 (cg-RX-API-DMAC7.html)
JP2015507921A5 (cg-RX-API-DMAC7.html)
JP2011529706A5 (cg-RX-API-DMAC7.html)
JP2018184448A5 (cg-RX-API-DMAC7.html)
HRP20240842T1 (hr) Imunološki uočljive varijante stanične površine za upotrebu u staničnoj terapiji
JP2023537534A5 (cg-RX-API-DMAC7.html)
PH12011000365A1 (en) Polyglyceryl compounds and compositions
IL300460A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
EP3154599B1 (en) Hybrid composition
AU2016305550A1 (en) Immuno-oncology mesodermal progenitor (ioMP) cell
JP2022534813A (ja) Cd33改変のための組成物および方法
JP2024534387A (ja) 造血細胞におけるマルチプレックス塩基編集のための組成物及び方法
JP2017520583A5 (cg-RX-API-DMAC7.html)
US20240417755A1 (en) Fusion polypeptides for genetic editing and methods of use thereof
CN107354183A (zh) 一种低分子量壳寡糖的制备方法
US20240200059A1 (en) Photocleavable guide rnas and methods of use thereof
JP5078097B2 (ja) セルロースエーテルを挽く方法